Medannot Secures Funding From Zero One Hundred to Enable No-Code AI Automation for Radiology Workflows

September 04, 2024 06:08 AM AEST | By EIN Presswire
 Medannot Secures Funding From Zero One Hundred to Enable No-Code AI Automation for Radiology Workflows
Image source: EIN Presswire
BRUSSELS, BELGIUM, September 3, 2024 /EINPresswire.com/ -- Medannot, a cloud-based radiology platform specializing in 3D imaging, is thrilled to announce the successful completion of its funding round led by Zero One Hundred. This investment will accelerate the development and expansion of Medannot’s platform, which empowers clinicians to create and deploy artificial intelligence models for a wide range of radiology applications—without any coding experience.

The platform is transforming how radiologists and clinicians leverage AI by making it accessible to everyone. It offers an intuitive, browser-based annotator that integrates seamlessly with the latest picture archiving solutions (PACS). The integrations allow clinicians to annotate medical images directly in the browser and start training AI models with as few as five images. The user-friendly design and rapid deployment capabilities ensure that any clinician, regardless of technical background, can develop AI models for diverse applications, ranging from diagnostics to 3D modeling.

“There is a lot of repetition in radiology. Yet, only a small fraction of the tasks are automated as AI companies struggle to keep up with the huge unmet clinical needs,” said Pieter De Backer, MD, PhD, MScEng, Co-Founder of Medannot. “We’ve fundamentally changed the approach by enabling clinicians to become the AI developers themselves. With our platform, they can create, train, and deploy AI models tailored to their specific needs, allowing them to address these gaps more effectively and at an unprecedented pace.”

Medannot already features an AI store with more than 50 AI models, offering a wide range of capabilities to enhance radiology workflows. Notable examples include an AI model for detecting lung cancer in CT scans, a tool that automates the segmentation of maxillofacial bones and surrounding tissues to facilitate the precise identification of vessels for grafts and flaps in reconstructive surgeries and an AI that allows for non-invasive colonoscopies using Medannot’s Virtual Reality features.

The platform was also recently utilized to guide 3D robotic surgery in a clinical trial. In this trial, an auto-generated 3D surgical model was overlaid using augmented reality directly within the robot's video feed as a reference.

Clinicians using Medannot can collaborate on the development and multicentric validation of these AI models, ensuring their effectiveness in real-world clinical settings. The platform also provides the required regulatory infrastructure and takes charge of the certification process, using the clinical evidence built by the community to guide these models through FDA and MDR approval. Finished models can be listed in the AI store, allowing clinicians who created or helped validate them to financially profit from their use.

“This collaborative approach accelerates the development and adoption of AI in radiology and provides a new revenue stream for clinicians and hospitals, empowering them to contribute directly to the advancement of medical technology,” adds MScEng. Robert Klein, Co-Founder & CTO.

“The investment from Zero One Hundred underscores their dedication to advancing healthcare innovation,” said Martin Herman, a Board Member at Medannot, who has partnered with Zero One Hundred on another successful medical startup Powerful Medical, a medical device manufacturer specializing in AI-powered ECG diagnostics. He further emphasized the value of their support. “Zero One Hundred has been a steadfast and reliable partner, particularly in ventures that challenge and redefine medical technology.”

PR Team
MEDANNOT
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.